1116654-52-4

Upstream product

• 7404-35-5 1,2,3,4-tetra-O-acetyl-L-rhamnopyranose 
• 5158-64-5 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl bromide 
• 324041-27-2 1,2-(allyloxyethylidene)-β-L-rhamnopyranose 
• 1091625-31-8 3,4-di-O-benzyl-1,2-(allyloxyethylidene)-β-L-rhamnopyranose 
• 89821-77-2 Allyl 4-O-benzyl-2,3-O-isopropylidene-α-L-rhamnopyranoside 
• 100639-25-6 allyl 2,3-O-isopropylidene-α-L-rhamnopyranoside 
• 64650-81-3 allyl α-L-rhamnopyranoside 
• 89821-78-3 allyl 4-O-benzyl-α-L-rhamnopyranoside 
• 100-39-0 benzyl bromide 
• 73-34-7 L-rhamnose 
• 119471-45-3 allyl 3,4-di-O-benzyl-α-L-rhamnosylpyranose 
• 824939-34-6 allyl 3,4-di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyranoside 

Relevant academic research and scientific papers

Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X

The present invention relates to compounds derived from sugars which reproduce the epitopes of Shigella flexneri serotypes 3a and X and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter of the present in

Synthesis of two tetra- and four pentasaccharide fragments of Shigella flexneri serotypes 3a and X O-antigens from a common tetrasaccharide intermediate

Relying on trichloroacetimidate chemistry, six tetra- and pentasaccharide fragments of the {2)-[α-D-Glcp-(1→3)]-α-L-Rhap-(1→2)- α-L-Rhap-(1→3)-[Ac→2]-α-L-Rhap-(1→3) -β-D-GlcpNAc-(1→}n ((E)ABAcCD)n polymer were synthesized